https://www.indianpharmapost.com/aurobindo-pharma-q2-fy25-net-profit-up-86-at-rs-817-cr-164172024-11-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-wellness-q2-fy25-sales-up-12-at-rs-4907-cr-164182024-11-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-receives-usfda-final-approval-for-diltiazem-hydrochloride-er-capsules-164192024-11-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/akums-drugs-and-pharmaceuticals-posts-q2-fy25-adjusted-pat-at-rs-667-cr-164202024-11-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-indovation-program-boosts-six-start-ups-with-rs-15-crore-grant-164212024-11-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-classifies-biocon-biologics-biocon-park-in-bengaluru-as-vai-164222024-11-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/orchid-pharma-q2-fy25-pat-up-26-yoy-driven-by-strategic-initiatives-for-market-expansion-164232024-11-11T00:00:00+05:30always0.9